Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 287

1.

Complications of anterior cervical discectomy and fusion using recombinant human bone morphogenetic protein-2.

Vaidya R, Carp J, Sethi A, Bartol S, Craig J, Les CM.

Eur Spine J. 2007 Aug;16(8):1257-65.

2.

Multilevel anterior cervical discectomy and fusion with and without rhBMP-2: a comparison of dysphagia rates and outcomes in 150 patients.

Lu DC, Tumialán LM, Chou D.

J Neurosurg Spine. 2013 Jan;18(1):43-9. doi: 10.3171/2012.10.SPINE10231.

PMID:
23157278
3.
4.

Use of polyetheretherketone spacer and recombinant human bone morphogenetic protein-2 in the cervical spine: a radiographic analysis.

Klimo P Jr, Peelle MW.

Spine J. 2009 Dec;9(12):959-66. doi: 10.1016/j.spinee.2009.05.008.

PMID:
19574105
5.

Complications in the use of rhBMP-2 in PEEK cages for interbody spinal fusions.

Vaidya R, Sethi A, Bartol S, Jacobson M, Coe C, Craig JG.

J Spinal Disord Tech. 2008 Dec;21(8):557-62. doi: 10.1097/BSD.0b013e31815ea897.

PMID:
19057248
6.

The safety and efficacy of anterior cervical discectomy and fusion with polyetheretherketone spacer and recombinant human bone morphogenetic protein-2: a review of 200 patients.

Tumialán LM, Pan J, Rodts GE, Mummaneni PV.

J Neurosurg Spine. 2008 Jun;8(6):529-35. doi: 10.3171/SPI/2008/8/6/529.

PMID:
18518673
7.

Is it safe to use recombinant human bone morphogenetic protein in posterior cervical fusion?

Hiremath GK, Steinmetz MP, Krishnaney AA.

Spine (Phila Pa 1976). 2009 Apr 20;34(9):885-9. doi: 10.1097/BRS.0b013e31819e334a.

PMID:
19531997
8.

Interbody fusion with allograft and rhBMP-2 leads to consistent fusion but early subsidence.

Vaidya R, Weir R, Sethi A, Meisterling S, Hakeos W, Wybo CD.

J Bone Joint Surg Br. 2007 Mar;89(3):342-5.

9.

Anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2: a prospective study of complications.

Malham GM, Parker RM, Ellis NJ, Blecher CM, Chow FY, Claydon MH.

J Neurosurg Spine. 2014 Dec;21(6):851-60. doi: 10.3171/2014.8.SPINE13524.

PMID:
25279655
10.
11.

Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion.

Shields LB, Raque GH, Glassman SD, Campbell M, Vitaz T, Harpring J, Shields CB.

Spine (Phila Pa 1976). 2006 Mar 1;31(5):542-7.

PMID:
16508549
12.

Anterior cervical discectomy and fusion involving a polyetheretherketone spacer and bone morphogenetic protein.

Boakye M, Mummaneni PV, Garrett M, Rodts G, Haid R.

J Neurosurg Spine. 2005 May;2(5):521-5.

PMID:
15945426
13.

Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine.

Smucker JD, Rhee JM, Singh K, Yoon ST, Heller JG.

Spine (Phila Pa 1976). 2006 Nov 15;31(24):2813-9.

PMID:
17108835
15.

Ultra-low-dose recombinant human bone morphogenetic protein-2 for 3-level anterior cervical diskectomy and fusion.

Pourtaheri S, Hwang K, Faloon M, Issa K, Mease SJ, Mangels D, Sinha K, Emami A.

Orthopedics. 2015 Apr;38(4):241-5. doi: 10.3928/01477447-20150402-04.

PMID:
25901613
16.

Cervical interbody fusion cages. An animal model with and without bone morphogenetic protein.

Zdeblick TA, Ghanayem AJ, Rapoff AJ, Swain C, Bassett T, Cooke ME, Markel M.

Spine (Phila Pa 1976). 1998 Apr 1;23(7):758-65; discussion 766.

PMID:
9563105
18.

Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis.

Crawford CH 3rd, Carreon LY, McGinnis MD, Campbell MJ, Glassman SD.

Spine (Phila Pa 1976). 2009 Jun 1;34(13):1390-4. doi: 10.1097/BRS.0b013e3181a2da08.

PMID:
19440166
19.

Usage of recombinant human bone morphogenetic protein in cervical spine procedures: analysis of the MarketScan longitudinal database.

Cole T, Veeravagu A, Jiang B, Ratliff JK.

J Bone Joint Surg Am. 2014 Sep 3;96(17):1409-16. doi: 10.2106/JBJS.M.01016.

PMID:
25187578
20.

Anterior cervical discectomy and fusion with implantable titanium cage: initial impressions, patient outcomes and comparison to fusion with allograft.

Moreland DB, Asch HL, Clabeaux DE, Castiglia GJ, Czajka GA, Lewis PJ, Egnatchik JG, Cappuccino A, Huynh L.

Spine J. 2004 Mar-Apr;4(2):184-91; discussion 191. Erratum in: Spine J. 2004 May-Jun;4(3):following table of contents.

PMID:
15016396
Items per page

Supplemental Content

Support Center